Johnson & Johnson (JNJ) Finished Goods (2012 - 2018)
Johnson & Johnson (JNJ) posted Finished Goods of $5.4 billion for Q4 2018, down 2.08% sequentially from $5.5 billion in Q3 2018, and up 1.28% YoY from $5.3 billion in Q4 2017.
Johnson & Johnson (JNJ) Finished Goods (2012 - 2018) Analysis & Trends
Johnson & Johnson has reported Finished Goods for 6 years, with the latest figure at $5.4 billion in Q4 2018.
- Quarterly Finished Goods rose 1.28% year-over-year to $5.4 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $5.4 billion (up 1.28% YoY) and the FY2018 annual result came in at $5.4 billion, up 1.28% from the prior year.
- Finished Goods slipped to $5.4 billion in Q4 2018 per JNJ's latest filing, from $5.5 billion in the prior quarter.
- Over five years, Finished Goods peaked at $5.5 billion in Q3 2018 and troughed at $4.5 billion in Q4 2014.
- A 4-year average of $5.1 billion and a median of $5.3 billion in 2017 frame the typical range for Finished Goods.
- The sharpest annual moves came in 2014 and 2018: Finished Goods gained 11.55% in 2014, then increased 1.28% in 2018.
- Over 4 years, Finished Goods stood at $4.5 billion in 2014, then gained by 8.14% to $4.9 billion in 2016, then rose by 8.86% to $5.3 billion in 2017, then advanced by 1.28% to $5.4 billion in 2018.
- According to Business Quant data, Finished Goods over the past three periods registered $5.4 billion, $5.5 billion, and $5.4 billion for Q4 2018, Q3 2018, and Q3 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.87 Bn | 632.12 Bn | 17.26 Bn |
| 2 | AbbVie | 470.09 Bn | 463.52 Bn | 12.70 Bn |
| 3 | Merck | 375.69 Bn | 368.55 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.40 Bn | 295.71 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.51 Bn | 252.61 Bn | 12.86 Bn |
| 6 | Amgen | 236.27 Bn | 222.28 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.86 Bn | 178.68 Bn | 6.22 Bn |
| 8 | Pfizer | 159.32 Bn | 147.62 Bn | 10.94 Bn |
| 9 | Gsk | 106.16 Bn | 101.99 Bn | 8.24 Bn |
| 10 | Sanofi | 55.12 Bn | 47.74 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 30, 2018 | 5.38 Bn |
| Sep 30, 2018 | 5.49 Bn |
| Jul 1, 2018 | 5.36 Bn |
| Dec 31, 2017 | 5.31 Bn |
| Jan 1, 2017 | 5.01 Bn |
| Jan 3, 2016 | 4.88 Bn |
| Dec 28, 2014 | 4.51 Bn |
| Dec 29, 2013 | 4.04 Bn |
| Dec 30, 2012 | 3.82 Bn |
| Jan 1, 2012 | 3.44 Bn |